<DOC>
	<DOCNO>NCT01674686</DOCNO>
	<brief_summary>The aim study evaluate effect sarpogrelate , selective serotonin receptor antagonist , high dose statin reduction coronary spasm patient variant angina .</brief_summary>
	<brief_title>The Effect Sarpogrelate High Dose Statin Reduction Coronary Spasm</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris , Variant</mesh_term>
	<mesh_term>Coronary Vasospasm</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<mesh_term>Sarpogrelate</mesh_term>
	<criteria>Clinical history chest pain compatible variant angina ; morning chest pain aggravate cold exposure . Angiographically proven coronary spasm ; TIMI flow &lt; 3 spontaneous coronary spasm intracoronary ergonovine spasm provocation test . Cardiac arrest coronary spasm Left main coronary spasm Significant fix coronary artery stenosis ; Diameter stenosis &gt; 70 % major epicardial artery coronary angiography Left ventricular ejection fraction &lt; 30 % Coagulation disorder bleed tendency ( Platelet count &lt; 50k , PT INR &gt; 2.0 ) Significant liver disease ( AST ALT &gt; 100 U/ml ) Renal failure ( SCr &gt; 2.0 mg/dl ) hypersensitivity statin Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Vasospasm</keyword>
	<keyword>Sarpogrelate</keyword>
	<keyword>Statin</keyword>
</DOC>